Does High PCT Warrant Longer Therapy? - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Does High PCT Warrant Longer Therapy?

In a planned BALANCE analysis, elevated day 7 procalcitonin was associated with higher mortality, but the small subgroup analysis found no evidence that extending antibiotics from 7 to 14 days improved outcomes.

  • By

  • Andrea Surnit

  • July 15, 2026

  • 4 min

Share

Does High PCT Warrant Longer Therapy?

Overview

A secondary analysis of the BALANCE trial indicates that elevated procalcitonin (PCT) levels after 7 days of antibiotic therapy may not be a reliable indicator for extending antibiotic therapy. The study found no significant benefit in extending antibiotic therapy based on high PCT levels.

Background

Understanding the role of procalcitonin (PCT) in guiding antibiotic therapy duration is crucial, especially in the context of bloodstream infections. Elevated PCT levels have been associated with increased mortality, yet their utility in determining the length of antibiotic treatment remains unclear.

Data Highlights

PCT Level90-Day Mortality
≥ 250 pg/mL22% (13 of 60)
< 250 pg/mL6% (4 of 65)

Key Findings

  • High PCT levels (≥ 250 pg/mL) were associated with increased 90-day mortality (22% vs. 6% for lower levels).
  • No significant differences in ICU mortality or hospital-free days were observed between high and low PCT groups.
  • Extending antibiotic therapy to 14 days did not improve outcomes in patients with elevated PCT levels.
  • Host factors may contribute to PCT elevations, limiting its use as a standalone guide for antibiotic duration.
  • The analysis included only 125 patients, limiting the statistical power of the findings.

Clinical Implications

Clinicians should be cautious in using elevated PCT levels as a sole indicator for extending antibiotic therapy duration.

Conclusion

The analysis indicates that elevated PCT levels may not warrant prolonged antibiotic therapy.

Related Resources & Content

  1. Wright JK, Muscedere J, JAMA Network Open, 2026 -- Procalcitonin to Guide 7 vs 14 Days of Antibiotics in Bloodstream Infections: A Secondary Analysis of the BALANCE Trial
  2. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026 | SCCM
  3. Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections | New England Journal of Medicine
  4. the asco post — Testosterone Recovery After Androgen-Deprivation Therapy Linked to Improved Survival in High-Risk Prostate Cancer
  5. The ASCO Post — Optimal Duration of Checkpoint Inhibition in Melanoma Is No More Than 2 Years
  6. The ASCO Post — Optimal Timing of Hormonal Therapy for Biochemically Recurrent Prostate Cancer Remains Unclear
  7. The ASCO Post — Should We Treat Rising PSA in Men With Castrate Androgen Levels?
  8. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026 | SCCM
  9. Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections | New England Journal of Medicine
  10. Procalcitonin to Guide 7 vs 14 Days of Antibiotics in Bloodstream Infections: A Secondary Analysis of the BALANCE Trial | Infectious Diseases | JAMA Network Open | JAMA Network

Original Source(s)

Does High PCT Warrant Longer Therapy?

  • by Andrea Surnit

  • July 15, 2026

Related Content

Knee sepsis may be rare across tibial fracture care

Investigators documented acute knee sepsis after both intra- and extra-articular nailing of open tibial shaft fractures.

Familial Transmission of Invasive Group A Streptococcus: A Case Series

  • July 7, 2026

Medical Oddities: The ghost that haunted a heart

From haunted hearts to toxic treats, medicine has a few Halloween tricks up its sleeve.